# Hatiora (Rhipsalis baccifera)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/hatiora
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-20
**Evidence Score:** 2 / 10
**Category:** Amazonian
**Also Known As:** Rhipsalis baccifera, Mistletoe cactus, Chain cactus, Wickerware cactus, Cassytha baccifera, Cactus muerdago, Sarcostemma bacciferum, Epiphyllum bacciferum

## Overview

Hatiora (Rhipsalis baccifera) is an Amazonian cactus containing flavonoids and phenolic compounds that demonstrate potent [anti-inflammatory](/ingredients/condition/inflammation) activity. Research shows its ethanolic stem extract achieved up to 96% inhibition in inflammatory models through mechanisms targeting inflammatory mediator pathways.

## Health Benefits

• [Anti-inflammatory](/ingredients/condition/inflammation) effects were observed in a rat paw edema model using ethanolic stem extract, achieving up to 96% inhibition at the higher dose of 200 mg/kg.[2] • The plant contains flavonoids and phenols, which are associated with potential anti-inflammatory properties, though specific mechanisms are not detailed.[1][2] • No acute toxicity was observed in Artemia salina at 100 mg/mL, suggesting a favorable safety profile in initial screenings.[1] • Preclinical evaluations in mice found no major toxicity at studied doses, maintaining normal hematological parameters.[1] • The plant is primarily used as an ornamental houseplant, indicating its safety for general cultivation and handling.[4][5]

## Mechanism of Action

Hatiora's anti-inflammatory effects are attributed to its flavonoid and phenolic compounds that appear to modulate inflammatory mediator release and reduce edema formation. The ethanolic stem extract likely inhibits cyclooxygenase and lipoxygenase pathways, though specific molecular targets require further investigation. The flavonoids may also scavenge [free radical](/ingredients/condition/antioxidant)s and reduce [pro-inflammatory cytokine](/ingredients/condition/inflammation) production.

## Clinical Summary

Current evidence for Hatiora is limited to preclinical animal studies using rat paw edema models. One study demonstrated dose-dependent [anti-inflammatory](/ingredients/condition/inflammation) effects with 200 mg/kg ethanolic stem extract achieving 96% inhibition of inflammation. The research focused on acute inflammatory responses rather than chronic conditions. No human clinical trials have been conducted to establish safety profiles or therapeutic efficacy in humans.

## Nutritional Profile

Nutritional macro/micronutrient data for Hatiora (Rhipsalis baccifera) is extremely limited in the literature, as research has focused primarily on its phytochemical and pharmacological properties rather than dietary composition. Known bioactive compounds include: flavonoids (unspecified glycosides and aglycones, concentrations not precisely quantified in published literature) and phenolic compounds (total phenolic content detected in ethanolic stem extracts, contributing to observed [antioxidant](/ingredients/condition/antioxidant) and [anti-inflammatory](/ingredients/condition/inflammation) activity). The plant belongs to the Cactaceae family; like other cacti, stems likely contain mucilaginous polysaccharides (structural carbohydrates), modest fiber content, and high water content typical of succulent tissue. Small berry-like fruits (baccifera = berry-bearing) may contain simple sugars, organic acids, and vitamin C analogous to other Rhipsalis species, though specific concentrations are unquantified. No documented protein, fat, or micronutrient (vitamins/minerals) quantification exists in peer-reviewed sources for this species specifically. Bioavailability of its flavonoid and phenolic constituents is inferred from the demonstrated in vivo anti-inflammatory effect (96% inhibition at 200 mg/kg in rat paw edema model using ethanolic extract), suggesting adequate absorption of active fractions. The ethanolic extraction method implies lipophilic and moderately polar compound recovery; aqueous bioavailability of phenolics may differ.

## Dosage & Preparation

Preclinical studies used ethanolic stem extract at 100-200 mg/kg in rats for [anti-inflammatory](/ingredients/condition/inflammation) effects. No clinically studied dosages exist for humans. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Safety data for Hatiora supplementation in humans is currently unavailable due to lack of clinical studies. As with other cactus-derived supplements, potential gastrointestinal upset may occur at higher doses. Drug interactions are unknown but caution is advised when combining with [anti-inflammatory](/ingredients/condition/inflammation) medications due to potential additive effects. Pregnant and breastfeeding women should avoid use due to insufficient safety data.

## Scientific Research

No human clinical trials or meta-analyses have been identified for Rhipsalis baccifera, as per the available sources. Evidence is limited to in vitro and animal studies, with no PMIDs available for human research.

## Historical & Cultural Context

Rhipsalis baccifera has been noted for its traditional use as a commonly found epiphytic cactus in various regions. It has primarily been cultivated as a low-maintenance ornamental plant, with no specific historical medicinal contexts detailed in the research.

## Synergistic Combinations

Curcumin, Boswellia, Ginger, Turmeric, Green tea

## Frequently Asked Questions

### What is the effective dosage of Hatiora for inflammation?

Animal studies used 200 mg/kg of ethanolic stem extract for maximum anti-inflammatory effects. However, human dosing guidelines have not been established since no clinical trials exist.

### How long does it take for Hatiora to show anti-inflammatory effects?

In rat studies, Hatiora extract showed rapid anti-inflammatory activity within hours of administration in acute edema models. Human onset time is unknown due to lack of clinical data.

### Can Hatiora be taken with other anti-inflammatory supplements?

Combining Hatiora with other anti-inflammatory compounds may cause additive effects, potentially increasing bleeding risk. Consult healthcare providers before combining with NSAIDs or other anti-inflammatory supplements.

### What part of the Hatiora plant is used medicinally?

Research has focused on ethanolic extracts from Hatiora stems, which contain the highest concentrations of bioactive flavonoids and phenolic compounds. Traditional use may involve other plant parts.

### Is Hatiora the same as other Rhipsalis species?

Hatiora was formerly classified as Rhipsalis baccifera but is now considered a distinct genus. While related, different Rhipsalis species may have varying chemical profiles and bioactivity levels.

### What is the safety profile of Hatiora (Rhipsalis baccifera) based on toxicity studies?

Hatiora has demonstrated a favorable safety profile in preclinical testing, with no acute toxicity observed in Artemia salina at concentrations up to 100 mg/mL. While animal studies suggest good tolerability, human clinical safety data remains limited, and more comprehensive toxicology studies are needed to establish long-term safety in supplement form.

### How does the extract form of Hatiora affect its anti-inflammatory effectiveness?

Ethanolic stem extracts of Hatiora have shown the strongest anti-inflammatory effects in research models, achieving up to 96% inhibition of paw edema at 200 mg/kg doses. The extraction method appears to concentrate flavonoids and phenolic compounds responsible for these effects, suggesting that extract forms may be more bioavailable than whole plant material.

### Who should consider Hatiora supplementation for anti-inflammatory support?

Hatiora may be beneficial for individuals seeking natural anti-inflammatory support, particularly those interested in traditional herbal remedies with emerging scientific validation. However, those with existing inflammatory conditions, pregnant women, and individuals taking anticoagulant or anti-inflammatory medications should consult a healthcare provider before use, as interaction studies are limited.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*